Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.
about
Chlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategies21-O-angeloyltheasapogenol E3, a novel triterpenoid saponin from the seeds of tea plants, inhibits macrophage-mediated inflammatory responses in a NF-κB-dependent manner.Involvement of the Antioxidant Effect and Anti-inflammatory Response in Butyrate-Inhibited Vascular Smooth Muscle Cell ProliferationMolecular mechanism of protopanaxadiol saponin fraction-mediated anti-inflammatory actions.Impact of eNOS-Dependent Oxidative Stress on Endothelial Function and Neointima Formation.Cytoprotective and Cytotoxic Effects of Rice Bran Extracts in Rat H9c2(2-1) Cardiomyocytes.Translational and post-translational regulation of mouse cation transport regulator homolog 1Lancemaside A from Codonopsis lanceolata modulates the inflammatory responses mediated by monocytes and macrophages.The protective effects of trace elements against side effects induced by ionizing radiationCharacteristics of Skeletal Muscle Fibers of SOD1 Knockout Mice.Anti-inflammatory activity of AP-SF, a ginsenoside-enriched fraction, from Korean ginsengSkeletal Muscle TRIB3 Mediates Glucose Toxicity in Diabetes and High- Fat Diet-Induced Insulin Resistance.ROS-mediated carbon monoxide and drug release from drug-conjugated carboxyboranes.1,8-Cineole ameliorates oxygen-glucose deprivation/reoxygenation-induced ischaemic injury by reducing oxidative stress in rat cortical neuron/glia.Reactive oxygen species regulate the quiescence of CD34-positive cells derived from human embryonic stem cells.AKT-targeted anti-inflammatory activity of calyx ethanolic extract
P2860
Q27009367-E0B5AAF0-0AF4-4405-93E6-76890064D14BQ34577704-0EFA12A3-ABAD-4830-8090-990E0C66D584Q34580750-C2138DAF-EBBD-43C0-9135-2E5454D2F0BDQ34719329-AF0D8030-2CD3-429F-BBA5-F6261D728BC0Q36086630-F8D07D83-FBB0-4B2D-8F3A-B11C30F57DC2Q36889777-1CBAAB7E-7943-4729-9CDA-0A3860227B79Q37005709-996D6B1A-661C-489B-A545-FF2574AA5055Q37694503-277CE74C-6AA4-4F3E-A73C-7A00F03B95E8Q38544302-07AC4B32-6079-4D87-9AAA-0AA0BB5FAA32Q41332692-8D98AB94-CD82-4D36-BD00-913BFE335D7DQ41577043-C0C00DA8-EA20-49BC-B5CA-9E15DC65D24EQ42005197-A0761AB5-4F22-4C50-AEE6-40028496F00AQ46241550-38C022D1-EC16-4CF7-AAC4-741E1EAB0BD4Q46857078-BB602C5E-C8AF-442B-B478-80DE6DF8EDCAQ46903669-A866D62C-BD3C-4269-A548-0997BB019DE7Q58595391-D4AE6EE0-5F88-4047-A711-4AE7826C172F
P2860
Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.
@en
Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.
@nl
type
label
Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.
@en
Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.
@nl
prefLabel
Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.
@en
Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.
@nl
P2860
P1476
Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease.
@en
P2093
Dong Hoon Kang
Sang Won Kang
P2860
P356
10.4062/BIOMOLTHER.2013.015
P577
2013-03-01T00:00:00Z